Generic drugs. The same molecule after the patent.
It is an entire industry.
It exists to relieve Lifelong medication at monopoly prices. That is the whole reason it is here: nothing enters this map without a human problem behind it.
It could not exist without Pharmaceutical industry and Patent law. These are the quiet preconditions — remove any one and the solution stops working.
5 organisations in this map sell it, 4 of them publicly listed.
Its neighbourhood
Everything this entry connects to directly. Click any point to follow it.
The line back to a human being
4 hops from a person at a phase of life. The further a thing sits from the person, the more abstract it looks — and the more it tends to be mistaken for something that came from nowhere.
- SolutionGeneric drugs
- FrictionLifelong medication at monopoly prices
- SolutionChronic-condition pharmaceuticals
- FrictionThe body starts to fail in ways it did not before
- Life phaseMidlife
- Rooted inMortality
- Rooted inSafety
- Rooted inScarce resources
Relieves
Requires
Who sells it
| Organisation | Value | Type | Products |
|---|---|---|---|
| Samsung Biologics | $50B | public · 207940 | biologics contract manufacturing |
| Sun Pharmaceutical | $45B | public · SUNPHARMA | generics, specialty dermatology |
| WuXi AppTec | $30B | public · 2359 | contract drug development and manufacturing |
| Teva Pharmaceutical | $20B | public · TEVA | generic drugs, Austedo |
| Food and Drug Administration | government | infant formula standards, nutrition labelling, drug approval |